Skip to search formSkip to main contentSkip to account menu

lenperone

Known as: 4'-fluoro-4-(4-(p-fluorobenozyl)piperidino)butyrophenone 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Butyrophenones
lenperone hydrochloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2014
Review
2014
Metabolic Consequences of Antipsychotic Medication in Youths with Type 1 Diabetes: Analysis from the Prospective Nationwide German and Austrian Diabetes Survey DPV
1985
1985
Blood pressure response to acetylpromazine and lenperone in halothane anesthetized dogs
1977
1977
Antipsychotic effects, side effects and effective dosis of the butyrophenone lenperone (AHR 2277).
Three open studies with Lenperone were performed. 50 hospitalized schizophrenic patients were treated 20-30 days with Lenperone… 
1976
1976
Pilot open-label study of lenperone (AHR 2277), a butyrophenone, in anxiety.
1976
1976
Pilot open-label study of lenperone (AHR 2277), a butyrophenone, in anxiety.
1974
1974
An early clinical trial of lenperone (AHR 2277), a butyrophenone, in chronic schizophrenia.
1974
1974
Assessment of antipsychotic activity of a butyrophenone analogue, lenperone (AHR 2277).
1973
1973
Dose calibration studies of lenperone, a new tranquilizer for dogs, cats and swine.
1973
1973
Dose calibration studies of lenperone, a new tranquilizer for dogs, cats and swine.
1968
1968
Lenperone: a controlled evaluation in chronic schizophrenic patients.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)